Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls. Objectives: ...

Credit: Getty Images. Lisdexamfetamine dimesylate capsules and chewable tablets are indicated for ADHD in patients aged 6 years and older, and for moderate to severe binge-eating disorder in adults.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The Medical – Generic Drugs industry comprises companies ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved multiple first generics of Vyvanse capsules and chewable tablets for ADHD in patients aged ...

CivicaScript released a generic version of dalfampridine, a drug used to improve walking in patients with multiple sclerosis, for $16 per bottle of 60 extended-release, 10-milligram tablets. The price ...

The latest update is out from Mirum Pharmaceuticals ( (MIRM)). In November 2025, Mirum Pharmaceuticals received Paragraph IV certification notice letters from multiple generic drug makers, including ...

(Reuters) - Teva Pharmaceutical Industries Ltd, the world's biggest maker of generic drugs, announced an ambitious plan on Friday to reshape the company as it faces increased competition for its ...

For the quarter that ended June 2023, multiple generic drugmakers like Amphastar Pharmaceuticals AMPH, Dr. Reddy’s Laboratories RDY and Teva Pharmaceutical TEVA noted that the generic price erosion in ...